Latest Drug Approvals news
FDA Approves Welireg With Pembrolizumab for Renal Cell Carcinoma
posted June 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Rapid-Acting Inhaled Insulin for Children
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First New Sunscreen Ingredient in Two Decades
posted June 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Xocova for COVID-19 Postexposure Prophylaxis
posted June 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Related Articles
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children 
Time From Drug Approval to Reimbursement Longer in U.S. Than Some European Countries 
FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular Dystrophy Monthly Specialist Briefings
Stay Connected
